Guildford, UK-based online design consultancy Harlequin Solutions has appointed Sandrine Desmares-Vaury as marketing manager. “I am delighted to be joining …

Venture capital is a curious business. The global financial crisis which we are slowly emerging from has exposed some rather …
Dr Graham Cook, a senior director in the Global Quality and Compliance division of Wyeth Pharmaceuticals, has joined the British …
Oscar Podesta, Chiltern Executive Director, Latin America, leads this endeavor. “Our office, strategically located in suburban Pilar, is a natural …
UK drug delivery specialist PolyTherics has raised an additional £3 million in funding as it extends the focus of its …

The custom synthesis division of chemicals giant BASF has joined forces with processing equipment specialist GEA Niro to broaden its …
Merck’s merger with Schering-Plough in October has helped boost the company’s full year sales by 13% to $27.4 billion.The gain …
AstraZeneca is looking to enter the lucrative rheumatoid arthritis market by in-licensing a phase II treatment.The global market for rheumatoid …
PharmaNet Development Group has named Dr Steven Leventer to the position of vice president, clinical research – neuroscience. Leventer joins …

Cephalon UK’s senior product manager Paul Jewsbury lost his long and hard-fought battle against a recurring brain tumour in December.Paul, …

Cancer Research Technology, the development and commercial arm of Cancer Research UK, has reached an agreement to collaborate with German-based …

Abbott has completed its $6.2 billion acquisition of Solvay’s pharma division.The acquisition is expected to add $2.9 billion to Abbott’s …
The ABPI has come out on top in the opening salvo of its unprecedented European legal challenge against prescribing incentive …
Research funded by the Chartered Institue of Management Accountants (CIMA) has helped Cranfield School of Management unveil a new framework …

GlaxoSmithKline has appointed Adrian Hodges to head up corporate responsibility and community partnerships. He moves to the pharma company after …

The British Medical Association is urging the public to resist the role of private companies in the NHS. Its Look …
MDS has completed the sell-off of its contract research and development business – MDS Pharma Services – with the signing …

NICE has given a partial green light to Novo Nordisk’s type II diabetes treatment Victoza, backing its use as part …
Sanofi-Aventis has expanded its My Child Matters programme, adding another seven new projects for improving cancer care for children in …
Jan van Heek has joined Amarin’s board of directors of as a non-executive director and will also take on the role …